Lung transplant (LT) recipient characteristics according to primary graft dysfunction grade 3 (PGD3) development in the first 72 h
| No PGD3 | PGD3 | p-value | |
| 肝移植受者 | 39 | 31 | |
| Preoperative characteristics | |||
| Age years | 55±12 | 55±9 | 0.84 |
| Females | 12 (31%) | 17 (55%) | 0.05 |
| BMI kg·m−2 | 26±8 | 27±5 | 0.66 |
| Aetiology | 0.07 | ||
| Pulmonary fibrosis | 9 (23%) | 14 (45%) | |
| COPD | 18 (46%) | 14 (45%) | |
| Pulmonary hypertension | 2 (5%) | 2 (7%) | |
| Cystic fibrosis | 6 (16%) | 0 (0%) | |
| Others | 4 (10%) | 1 (3%) | |
| Haemoglobin g·dL−1 | 14±2 | 14±2 | 0.88 |
| Plasma protein level g·dL−1 | 7.4±0.7 | 7.3±0.7 | 0.44 |
| Intraoperative characteristics | |||
| Procedure type: | |||
| 双边LT | 25 (64%) | 20 (65%) | 1.00 |
| CPB use | 4 (10%) | 9 (29%) | 0.06 |
| Blood product transfusion packs | 2 (4%) | 4 (6%) | 0.18 |
| iNO use | 13 (33%) | 25 (81%) | <0.01 |
| For hypoxaemia | 1 (8%) | 16 (64%) | 0.01 |
| For PH | 11 (84%) | 19 (76%) | 0.26 |
| Ischaemia time min | 299±76.0 | 332±64.8 | 0.05 |
| Postoperative characteristics | |||
| ICU mortality | 0 (0%) | 5 (16%) | 0.02 |
| Hospital mortality | 0 (0%) | 7 (23%) | <0.01 |
| 28-day mortality | 0 (0%) | 4 (13%) | 0.03 |
| 90-day mortality | 0 (0%) | 6 (19%) | <0.01 |
| ICU LOS days | 22±23 | 32±15 | 0.04 |
| MV length days | 16±22 | 28±18 | 0.02 |
Data are presented as mean±sdunless otherwise stated. BMI: body mass index; COPD: chronic obstructive pulmonary disease; CPB: cardiopulmonary bypass; iNO: inhaled nitric oxide; PH: pulmonary hypertension; ICU: intensive care unit; LOS: length of stay; MV: mechanical ventilation.